The Slow March toward Rapid Phenotypic Antimicrobial Susceptibility Testing: Are We There Yet?
- PMID: 29436417
 - PMCID: PMC5869850
 - DOI: 10.1128/JCM.01999-17
 
The Slow March toward Rapid Phenotypic Antimicrobial Susceptibility Testing: Are We There Yet?
Abstract
Antimicrobial susceptibility testing (AST) provides critical information for the management of patients with infections. The gold standard methods for assessing organism susceptibility are still based on growth and require incubation over relatively long periods of time. Until now, little progress has been made in developing rapid, growth-based, phenotypic AST systems. This commentary puts the recently FDA-cleared Accelerate PhenoTest (P. Pancholi et al., J Clin Microbiol 56:e01329-17, 2018, https://doi.org/10.1128/JCM.01329-17) in context by providing a historical perspective on attempts to accelerate phenotypic susceptibility results. In addition, some promising new innovations that promise to shorten the turnaround time for phenotypic AST will be briefly reviewed.
Keywords: blood culture; phenotypic; rapid; susceptibility testing.
Copyright © 2018 American Society for Microbiology.
Comment on
- 
  
  Multicenter Evaluation of the Accelerate PhenoTest BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular Analysis.J Clin Microbiol. 2018 Mar 26;56(4):e01329-17. doi: 10.1128/JCM.01329-17. Print 2018 Apr. J Clin Microbiol. 2018. PMID: 29305546 Free PMC article.
 
References
- 
    
- Sullivan KV, Turner NN, Roundtree SS, Young S, Brock-Haag CA, Lacey D, Abuzaid S, Blecker-Shelly DL, Doern CD. 2013. Rapid detection of Gram-positive organisms by use of the Verigene Gram-positive blood culture nucleic acid test and the BacT/Alert pediatric FAN system in a multicenter pediatric evaluation. J Clin Microbiol 51:3579–3584. doi:10.1128/JCM.01224-13. - DOI - PMC - PubMed
 
 
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
